<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8578854</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">34776847</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8578854</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnins.2021.738708</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Timeline of diagnostics and therapeutic interventions.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1</label><caption><p>Timeline of diagnostics and therapeutic interventions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time (months from initial diagnosis)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Diagnostics/interventions</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">Generalized seizure,<break/> structural brain MRI, and FET-PET</td><td valign="top" align="left" rowspan="1" colspan="1">Left parietal, contrast-enhancing, and FET-PET-positive lesion</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">Resection of lesion</td><td valign="top" align="left" rowspan="1" colspan="1">Singular metastasis, histopathological type: adenocarcinoma</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2–3</td><td valign="top" align="left" rowspan="1" colspan="1">Whole brain irradiation,<break/> 30 Gy in 10 fractions</td><td valign="top" align="left" rowspan="1" colspan="1">Well tolerated</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">Right upper lobectomy for resection of primary tumor, mediastinal lymphadenectomy</td><td valign="top" align="left" rowspan="1" colspan="1">NSCLC, involvement of mediastinal lymph nodes, Stage IV</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6–9</td><td valign="top" align="left" rowspan="1" colspan="1">Adjuvant chemotherapy, four courses of cisplatin/ vinorelbine</td><td valign="top" align="left" rowspan="1" colspan="1">Complete remission of primary tumor</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">10–132</td><td valign="top" align="left" rowspan="1" colspan="1">Follow-up including repeated chest CT and structural brain MRI and FET-PET, no further oncologic interventions</td><td valign="top" align="left" rowspan="1" colspan="1">Complete remission of primary tumor and brain metastasis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">132</td><td valign="top" align="left" rowspan="1" colspan="1">Last follow-up, structural brain MRI, resting-state fMRI, and FET-PET</td><td valign="top" align="left" rowspan="1" colspan="1">Development of bilateral white matter lesions</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Timeline of diagnostics and therapeutic interventions.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Time (months from initial diagnosis)</th><th valign="top" align="left">Diagnostics/interventions</th><th valign="top" align="left">Outcome</th></tr></thead><tbody><tr><td valign="top" align="left">0</td><td valign="top" align="left">Generalized seizure, structural brain MRI, and FET-PET</td><td valign="top" align="left">Left parietal, contrast-enhancing, and FET-PET-positive lesion</td></tr><tr><td valign="top" align="left">1</td><td valign="top" align="left">Resection of lesion</td><td valign="top" align="left">Singular metastasis, histopathological type: adenocarcinoma</td></tr><tr><td valign="top" align="left">2–3</td><td valign="top" align="left">Whole brain irradiation, 30 Gy in 10 fractions</td><td valign="top" align="left">Well tolerated</td></tr><tr><td valign="top" align="left">4</td><td valign="top" align="left">Right upper lobectomy for resection of primary tumor, mediastinal lymphadenectomy</td><td valign="top" align="left">NSCLC, involvement of mediastinal lymph nodes, Stage IV</td></tr><tr><td valign="top" align="left">6–9</td><td valign="top" align="left">Adjuvant chemotherapy, four courses of cisplatin/ vinorelbine</td><td valign="top" align="left">Complete remission of primary tumor</td></tr><tr><td valign="top" align="left">10–132</td><td valign="top" align="left">Follow-up including repeated chest CT and structural brain MRI and FET-PET, no further oncologic interventions</td><td valign="top" align="left">Complete remission of primary tumor and brain metastasis</td></tr><tr><td valign="top" align="left">132</td><td valign="top" align="left">Last follow-up, structural brain MRI, resting-state fMRI, and FET-PET</td><td valign="top" align="left">Development of bilateral white matter lesions</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>